CS Diagnostics Corp.
CSDX
$0.10
$0.0226.16%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -12.20K | -27.30K | 17.20K | 100.00 |
| Total Other Revenue | 204.00K | 110.90K | 110.90K | 110.90K | 110.90K |
| Total Revenue | 204.00K | 98.70K | 83.60K | 128.10K | 111.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 204.00K | 98.70K | 83.60K | 128.10K | 111.00K |
| SG&A Expenses | 132.80K | 79.30K | 63.50K | 103.80K | 110.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.80K | 79.30K | 63.50K | 103.80K | 110.10K |
| Operating Income | 71.20K | 19.40K | 20.10K | 24.20K | 700.00 |
| Income Before Tax | 71.20K | 19.40K | 20.10K | 24.20K | 700.00 |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.07 | 0.02 | 0.02 | 0.02 | 0.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.20K | 19.40K | 20.10K | 24.20K | 700.00 |
| EBIT | 71.20K | 19.40K | 20.10K | 24.20K | 700.00 |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 999.88M | 591.49M | 583.85M | 569.71M | 543.16M |
| Average Diluted Shares Outstanding | 999.88M | 591.49M | 583.85M | 569.71M | 543.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |